Zhejiang Barty Medical Technology Co., Ltd. (“Barty Medical”) is a national high-tech enterprise dedicated to the R&D, manufacturing and sales of medical devices in the field of vascular intervention.
Founded in August 2015, the company is located in Hangzhou city. It has a 1,900 ㎡ GMP class 10,000 (partially class 100) cleanroom, equipped with professional and complete facilities and equipment.
Barty Medical focuses on cardiovascular intervention and peripheral vascular intervention areas. Currently, Barty Medical has acquired more than 50 patents, 9 NMPA registration, and 8 CE certificates.
Barty Medical has established a comprehensive sales team. Domestic business has covered more than 1,300 hospitals in 31 provinces, cities, and autonomous regions. Overseas business includes South Korea, Turkey, Malaysia, Brazil and more than 20 other countries and regions.
The company upholds the business philosophy of “market-oriented, R&D-driven, and manufacturing-based”, and integrates the pursuit of quality and innovation into Barty’s genes. We aspire to become a leader in the field of vascular intervention, continue to explore the latest medical technology and transform the technology into innovative products. Barty aims to provide our innovations to the forefront of medical treatment, support doctors to grow, thus benefit patients. Let medical technology bloom the light of life.